Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Iolanda Capone"'
Autor:
Marco Maria Germani, Guglielmo Vetere, Mirella Giordano, Paolo Ciracì, Iolanda Capone, Elena Tamborini, Elena Conca, Adele Busico, Filippo Pietrantonio, Vittoria Matilde Piva, Alessandra Boccaccino, Francesca Simionato, Martina Bortolot, Paolo Manca, Sara Lonardi, Veronica Conca, Beatrice Borelli, Martina Carullo, Marzia Del Re, Gabriella Fontanini, Daniele Rossini, Chiara Cremolini
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundRetreatment with anti-EGFR monoclonal antibodies is a promising strategy in patients with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) who achieved benefit from previous anti-EGFR exposure upon exclusion of mutations in RAS/B
Externí odkaz:
https://doaj.org/article/119b59c1dc1d407698a8eee5621f82dc
Autor:
Jacopo Azzollini, Luca Agnelli, Elena Conca, Tommaso Torelli, Adele Busico, Iolanda Capone, Marta Angelini, Elena Tamborini, Federica Perrone, Andrea Vingiani, Daniele Lorenzini, Bernard Peissel, Giancarlo Pruneri, Siranoush Manoukian
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Tumour DNA sequencing is essential for precision medicine since it guides therapeutic decisions but also fosters the identification of patients who may benefit from germline testing. Notwithstanding, the tumour-to-germline testing workflow p
Externí odkaz:
https://doaj.org/article/1201518e80a843888ac0f10a86f7d812
Autor:
Iolanda Capone, Fabio Bozzi, Gian Paolo Dagrada, Paolo Verderio, Elena Conca, Adele Busico, Maria Adele Testi, Valentina Monti, Matteo Duca, Claudia Proto, Silvia Damian, Alberta Piccolo, Federica Perrone, Elena Tamborini, Andrea Devecchi, Paola Collini, Daniele Lorenzini, Andrea Vingiani, Luca Agnelli, Giancarlo Pruneri
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 3, Iss 5, Pp 582-597 (2022)
Aim: Diagnostic laboratories are progressively introducing next-generation sequencing (NGS) technologies in the routine workflow to meet the increasing clinical need for comprehensive molecular characterization in cancer patients for diagnosis and pr
Externí odkaz:
https://doaj.org/article/d74b17c328cc45588837b22f3835282c
Autor:
Shigeki Kusamura, Adele Busico, Elena Conca, Iolanda Capone, Luca Agnelli, Daniele Lorenzini, Silvia Brich, Marta Angelini, Chiara Costanza Volpi, Desirè Viola Trupia, Vincenzo Lagano, Tommaso Torelli, Annunziata Gloghini, Dario Baratti, Marcello Guaglio, Massimo Milione, Marcello Deraco, Federica Perrone
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 2049 (2023)
In pseudomyxoma peritonei (PMP), KRAS and GNAS mutations are frequent. We hypothesized that these mutations may contribute to the suppression of antitumor immunity: KRAS may induce GMCSF expression, while GNAS may enhance the expression of cyclic ade
Externí odkaz:
https://doaj.org/article/bcdd95d8ae5e422d8150f874928f4e69
Autor:
Vito Longo, Annamaria Catino, Michele Montrone, Pamela Pizzutilo, Francesco Pesola, Ilaria Marech, Iolanda Capone, Arsela Prelaj, Domenico Galetta
Publikováno v:
Thoracic Cancer, Vol 12, Iss 13, Pp 2031-2034 (2021)
Abstract Patients with non‐small cell lung cancer (NSCLC) and uncommon epidermal growth factor receptor (EGFR) mutation are characterized by high heterogeneity, and globally considered to have a worse prognosis than patients with the two common mut
Externí odkaz:
https://doaj.org/article/35e214ab38604b83854e2e888b4bfc36
Autor:
Jacopo Azzollini, Andrea Vingiani, Luca Agnelli, Elena Tamborini, Federica Perrone, Elena Conca, Iolanda Capone, Adele Busico, Bernard Peissel, Erica Rosina, Monika Ducceschi, Mara Mantiero, Salvatore Lopez, Francesco Raspagliesi, Monica Niger, Matteo Duca, Silvia Damian, Claudia Proto, Filippo de Braud, Giancarlo Pruneri, Siranoush Manoukian
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumour testing of the BRCA1/2 genes is routinely performed in patients with different cancer histological subtypes. To accurately identify patients with tumour-detected germline pathogenic variants (PVs) is a relevant issue currently under investigat
Externí odkaz:
https://doaj.org/article/9d4b24fca9bc4bd8a9558be46f0b6e5b
Autor:
Antonino Belfiore, Adele Busico, Fabio Bozzi, Silvia Brich, Elena Dallera, Elena Conca, Iolanda Capone, Annunziata Gloghini, Chiara C. Volpi, Antonello D. Cabras, Silvana Pilotti, Dario Baratti, Marcello Guaglio, Marcello Deraco, Shigeki Kusamura, Federica Perrone
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 22, p 5817 (2019)
Background—There are currently no effective therapies for diffuse malignant peritoneal mesothelioma (DMPM) patients with disease recurrence. In this study, we investigated the biology of DMPM by analyzing the EGFR family, Axl, and MET, in order to
Externí odkaz:
https://doaj.org/article/94604b5ad51c48e78ee5cc105b1a4b2e
Autor:
Federica Morano, Alessandra Raimondi, Filippo Pagani, Sara Lonardi, Lisa Salvatore, Chiara Cremolini, Sabina Murgioni, Giovanni Randon, Federica Palermo, Lorenzo Antonuzzo, Nicoletta Pella, Patrizia Racca, Michele Prisciandaro, Monica Niger, Francesca Corti, Francesca Bergamo, Alberto Zaniboni, Margherita Ratti, Michele Palazzo, Celeste Cagnazzo, Maria Alessandra Calegari, Federica Marmorino, Iolanda Capone, Elena Conca, Adele Busico, Silvia Brich, Elena Tamborini, Federica Perrone, Massimo Di Maio, Massimo Milione, Maria Di Bartolomeo, Filippo de Braud, Filippo Pietrantonio
Publikováno v:
Journal of Clinical Oncology. 40:1562-1573
PURPOSE This is a multicenter, single-arm phase II trial evaluating the efficacy and safety of an immune-sensitizing strategy with temozolomide priming followed by a combination of low-dose ipilimumab and nivolumab in patients with microsatellite-sta
Autor:
Pasquale Quattrone, Laura D. Locati, Salvatore Alfieri, Luigi Mariani, Paolo Bossi, Lisa Licitra, Cristiana Bergamini, Francesca Platini, Carlo Resteghini, Elena Colombo, Giuseppina Calareso, Iolanda Capone, Stefano Cavalieri
Publikováno v:
Journal of Clinical Oncology. 39:4061-4068
PURPOSE The activity of androgen-deprivation therapy (ADT) in androgen receptor–positive (AR+) salivary gland carcinomas (SGCs) has been established in the past few years. Second-line treatment in castration-resistant patients is still unknown. We
Autor:
Giacomo Massa, Anna Tessari, Silvia Damian, Matteo Duca, Elena Tamborini, Federica Perrone, Iolanda Capone, Biagio Paolini, Antonia Martinetti, Elisa Sottotetti, Filippo de Braud, Sara Cresta, Chiara Pircher
Background uterine tumor resembling sex-cord tumors of the ovary (UTROSCT) is a rare form of mesenchymal uterine tumor of uncertain malignancy. Sporadic cases of advanced disease are reported, but little is known about its management in the metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::265841bb1de92ecaa8087358cea7d2a6
https://doi.org/10.21203/rs.3.rs-2327010/v1
https://doi.org/10.21203/rs.3.rs-2327010/v1